|
|
||||||||
Ann Thorac Surg 1998;66:118-123
© 1998 The Society of Thoracic Surgeons
a Department of Anesthesiology, Mayo Foundation and Mayo Clinic, Rochester, Minnesota, USA
b Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Mayo Foundation and Mayo Clinic, Rochester, Minnesota, USA
Accepted for publication February 23, 1998.
Address reprint requests to Dr Cook, Department of Anesthesiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905
e-mail: (cook.david{at}mayo.edu)
Background. The management of blood pressure during cardiopulmonary bypass varies widely. This may be particularly relevant with the trend to warmer bypass temperatures and an older patient population. Therefore, we examined the minimal perfusion pressure that maintains cerebral oxygen delivery during cardiopulmonary bypass at 33°C.
Methods. Ten dogs were placed on bypass and body temperature was reduced to 33°C (
-stat pH management). At six randomly ordered mean arterial blood pressures (35, 40, 45, 50, 60, and 70 mm Hg), cerebral blood flow, oxygen delivery, and metabolic rate were determined.
Results. Cerebral oxygen delivery was stable if the mean arterial pressure was greater than or equal to 60 mm Hg. If mean arterial pressure was less than or equal to 50 mm Hg, cerebral oxygen delivery decreased, and at less than 45 mm Hg cerebral ischemia was seen.
Conclusions. In a dog without vascular disease, the brain becomes perfusion pressure-dependent at a mean arterial pressure of approximately 50 mm Hg. There is no leftward shift of the cerebral autoregulatory curve during bypass at 33°C. Greater support of mean arterial pressure during "tepid" cardiopulmonary bypass is indicated in the current adult surgical population that is older and has vascular comorbidity.
This article has been cited by other articles:
![]() |
J. C. Halstead, M. Meier, M. Wurm, N. Zhang, D. Spielvogel, D. Weisz, C. Bodian, and R. B. Griepp Optimizing selective cerebral perfusion: Deleterious effects of high perfusion pressures. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 784 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brueck, W. Kramer, P. Vogt, N. Steinert, P. Roth, G. Gorlach, M. Schonburg, and M. C. Heidt Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 108 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dworschak, M. Czerny, M. Grimm, G. Grubhofer, and W. Plochl The impact of asymptomatic carotid artery disease on the intraoperative course of coronary artery bypass surgery Perfusion, January 1, 2003; 18(1): 15 - 18. [Abstract] [PDF] |
||||
![]() |
D. J. Cook Optimal Conditions for Cardiopulmonary Bypass Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2001; 5(4): 265 - 272. [Abstract] [PDF] |
||||
![]() |
W. Plochl, D. J. Cook, T. A. Orszulak, and R. C. Daly Intracranial Pressure and Venous Cannulation for Cardiopulmonary Bypass Anesth. Analg., February 1, 1999; 88(2): 329 - 329. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |